Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$300M |
| 2 |
COL
Rockwell Collins
COL
|
+$137M |
| 3 |
Allison Transmission
ALSN
|
+$109M |
| 4 |
CF Industries
CF
|
+$79M |
| 5 |
MSCI
MSCI
|
+$44.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$82.5M |
| 2 |
GDI
GARDNER DENVER,INC
GDI
|
+$48.4M |
| 3 |
Bio-Techne
TECH
|
+$4.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.26% |
| 2 | Healthcare | 17.82% |
| 3 | Financials | 9.81% |
| 4 | Industrials | 8.03% |
| 5 | Real Estate | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.59T
| $2.23B | 20.1% |
66,865,530
+9,115,530
| +16% | +$300M |
|
2
Bausch Health
BHC
$2.41B
| $1.97B | 17.82% |
18,923,877
| – | – |
|
3
Motorola Solutions
MSI
$79.5B
| $1.72B | 15.49% |
28,907,623
| – | – |
|
4
Adobe
ADBE
$109B
| $1.63B | 14.67% |
31,303,362
| – | – |
|
|
COL
5
DELISTED
Rockwell Collins
COL
| $890M | 8.03% |
13,113,000
+1,932,991
| +17% | +$137M |
|
6
Willis Towers Watson
WTW
$31.8B
| $789M | 7.12% |
6,876,049
| – | – |
|
7
CBRE Group
CBRE
$44B
| $744M | 6.71% |
32,162,764
+161,300
| +0.5% | +$3.73M |
|
|
MCRS
8
DELISTED
MICROS SYSTEMS INC
MCRS
| $334M | 3.02% |
6,697,308
| – | – |
|
|
9
CF Industries
CF
$19.6B
| $298M | 2.69% |
7,061,000
+2,061,000
| +41% | +$79M |
|
|
10
MSCI
MSCI
$41B
| $298M | 2.69% |
7,394,017
+1,193,395
| +19% | +$44.6M |
|
|
11
Allison Transmission
ALSN
$11B
| $116M | 1.05% |
+4,625,204
| New | +$109M |
|
12
The Mosaic Company
MOS
$7.76B
| $24.8M | 0.22% |
+575,944
| New | +$26.8M |
|
|
OPLN
13
Openlane
OPLN
$4.08B
| $22.7M | 0.2% |
2,123,185
| – | – |
|
14
Valero Energy
VLO
$100B
| $21.8M | 0.2% |
+637,747
| New | +$22.5M |
|
|
15
Bio-Techne
TECH
$11.3B
| – | – |
-248,016
| Closed | -$4.28M |
|
|
GDI
16
DELISTED
GARDNER DENVER,INC
GDI
| – | – |
-643,400
| Closed | -$48.4M |
|
|
BCR
17
DELISTED
CR Bard Inc.
BCR
| – | – |
-758,704
| Closed | -$82.5M |
|
Similar funds
Mason Morfit's Q3 2013 Portfolio in Review
As of Q3 2013, Mason Morfit held 17 positions worth $11.1B, up 14% from $9.74B the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Mason Morfit deployed $587M of net new capital in Q3 2013, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was Allison Transmission: 4,625,204 shares worth $116M.
By sector, the portfolio is most concentrated in Technology at 50% of assets, down from 52% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the most notable exit was CR Bard Inc., an estimated $82.5M sold.
- Mason Morfit's largest Q3 2013 buy was Allison Transmission: 4,625,204 shares worth $116M.
- Mason Morfit added most to Microsoft in Q3 2013, an estimated $300M increase.
- Mason Morfit fully exited CR Bard Inc. in Q3 2013, selling an estimated $82.5M.
- Mason Morfit's ten largest holdings make up 98% of its $11.1B portfolio in Q3 2013.
- Mason Morfit opened 3 new positions and closed 3 in Q3 2013.
- Mason Morfit's portfolio value rose 14% quarter-over-quarter to $11.1B.
Based on ValueAct Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.